Castration-Resistant Prostatic Cancer
1 competing product in clinical development for Castration-Resistant Prostatic Cancer.
Pipeline by Phase
Phase 1/21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Docetaxel + Ifinatamab Deruxtecan + MK-5684 + Abiraterone + Enzalutamide + Rescue Medication | Daiichi Sankyo | Phase 1/2 | Recruiting | 39 |